GNXAX
Price
$14.46
Change
-$0.01 (-0.07%)
Updated
Sep 11 closing price
Net Assets
21.36M
RSLCX
Price
$76.30
Change
+$0.25 (+0.33%)
Updated
Sep 11 closing price
Net Assets
91.39B
Interact to see
Advertisement

GNXAX vs RSLCX

GNXAX vs RSLCX Comparison Chart in %
View a ticker or compare two or three
VS
GNXAX vs. RSLCX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNXAX is a Hold and RSLCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RSLCX has more cash in the bank: 91.4B vs. GNXAX (21.4M). RSLCX pays higher dividends than GNXAX: RSLCX (0.43) vs GNXAX (0.00). GNXAX was incepted earlier than RSLCX: GNXAX (9 years) vs RSLCX (24 years). GNXAX (2.59) is less costly to investors than RSLCX (1.30). GNXAX is a more actively managed with annual turnover of: 114.00 vs. RSLCX (41.00). RSLCX has a lower initial minimum investment than GNXAX: RSLCX (250) vs GNXAX (2500). RSLCX annual gain was more profitable for investors over the last year : 8.36 vs. GNXAX (-17.08). RSLCX return over 5 years is better than : -11.31 vs. GNXAX (-20.32).
GNXAXRSLCXGNXAX / RSLCX
Total Expense Ratio1.651.30127%
Annual Report Gross Expense Ratio2.591.30199%
Fund Existence9 years24 years-
Gain YTD-17.78412.074-147%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4M91.4B0%
Annual Yield % from dividends0.000.43-
Returns for 1 year-17.088.36-204%
Returns for 3 years35.7435.9499%
Returns for 5 years-20.32-11.31180%
Returns for 10 yearsN/A75.60-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCVRX28.60N/A
N/A
Goldman Sachs Large Cp Val Insghts R
MABAX20.14N/A
N/A
BlackRock Large Cap Focus Value Instl
LGLUX58.91N/A
N/A
Lord Abbett Growth Leaders R5
MXMTX11.48N/A
N/A
Empower Small Cap Growth Investor
AIHHX6.70N/A
N/A
Aristotle Small/Mid Cap Equity I-2